Gemcitabine Plus Cisplatin Versus Gemcitabine Plus Paclitaxel in Triple Negative Breast Cancer (TNBC)

NCT01287624 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

240

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Gemcitabine,cisplatin
DRUG: Gemcitabine, Paclitaxel

Sponsor

Fudan University

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]